Tuesday, May 05, 2026

 

Qubit Pharmaceuticals announces strategic collaboration with Singapore’s Centre for Quantum Technologies to advance quantum algorithms for drug discovery



National University of Singapore
Image 1 

image: 

Collaborators from Qubit Pharmaceuticals and the Centre for Quantum Technologies (CQT) met at the Quantum Industry Day in Singapore on 23 April 2026. Pictured from left: José Ignacio Latorre, CQT; Baptiste Claudon, Qubit Pharmaceuticals; Robert Marino, Qubit Pharmaceuticals; Sergi Ramos-Calderer, CQT.

view more 

Credit: Image credit: Centre for Quantum Technologies, Singapore





Paris / Singapore — 30 April 2026 — Qubit Pharmaceuticals today announced a strategic research collaboration with the Centre for Quantum Technologies (CQT) in Singapore to develop and use novel quantum algorithms for molecular discovery.

The two-year collaboration combines Qubit Pharmaceuticals’ expertise in quantum chemistry and sampling techniques with CQT’s deep capabilities in quantum computing, circuit design, and experimental implementation. The goal is to bring advanced quantum chemistry methods closer to real-world drug discovery applications.

Together, the teams are designing and testing algorithms for quantum chemistry, including variational quantum eigensolvers, quantum phase estimation, and quantum Markov Chain Monte Carlo (qMCMC) sampling. These algorithms target key computational bottlenecks in drug discovery, such as improving the accuracy of quantum chemistry calculations for better drug property predictions and enabling more efficient sampling techniques for molecular simulations.

 

“Quantum algorithms for chemistry have been studied for decades, but real implementations remain rare,” said Robert Marino, CEO of Qubit Pharmaceuticals. “By working with CQT and leveraging access to state-of-the-art quantum hardware, we aim to transition these algorithms from theoretical constructs into real computational tools for molecular discovery.”

“Recent progress in quantum hardware is exciting. We want to match this pace in developing quantum algorithms. We are glad to partner with domain experts like Qubit Pharmaceuticals to show what quantum computers can do for problems people care about,” said José Ignacio Latorre, Director of CQT and Provost’s Chair Professor at the National University of Singapore’s Department of Physics.

The researchers aim to explore whether quantum algorithms can approach the highest level of accuracy in molecular simulations while potentially delivering quadratic or even exponential computational advantages compared to classical approaches. They will validate their algorithms on quantum simulators before deploying to real quantum hardware.

The project is supported by Singapore’s National Quantum Computing Hub, through which CQT researchers have access to run experiments on Quantinuum’s quantum systems, including the H2 and Helios systems.

Marino and Baptiste Claudon presented first results from these experiments on 23 April at a Quantum Industry Day in Singapore organised by Quantinuum and Singapore’s National Quantum Office for some 250 invited participants.

The team has implemented the qMCMC algorithm, testing several different encodings. This is the first time this type of algorithm has been deployed to quantum hardware, and the team has published details to the physics preprint server arXiv (https://arxiv.org/abs/2603.08395).

The collaboration is led by Jean-Philip Piquemal at Qubit Pharmaceuticals and Sergi Ramos-Calderer at CQT, with an initial team of four researchers across both organisations. Additional researchers are expected to join as the programme expands.

  "Through our collaboration with Quantinuum, we have the opportunity to test quantum algorithms on some of the best gate-based quantum machines available today,” said Ramos-Calderer. “Algorithm design must move hand-in-hand with hardware improvements, and this work is a meaningful step in this direction."

 

“Drug discovery is fundamentally a molecular simulation challenge. If we can model chemistry with greater fidelity and efficiency, we can make better decisions earlier in the pipeline,” said Piquemal, Chief Scientific Officer / Co-founder, Qubit Pharmaceuticals. “This collaboration allows us to rigorously test whether quantum algorithms can move from scientific promise to practical utility on problems that matter.”

“We are interested in more than benchmark circuits or abstract demonstrations,” said Claudon, Quantum Physics Engineer, Qubit Pharmaceuticals. “Our focus is implementing algorithms that can address real computational bottlenecks in chemistry. Working with CQT and Quantinuum hardware gives us an opportunity to evaluate these methods under realistic conditions and learn what is required to make them useful for molecular discovery.”

Over the longer term, the team aims to generate real molecular simulation data produced directly by quantum algorithms and integrate these capabilities into future drug discovery workflows.

===

Media contacts

Chris Spillane

Qubit Pharmaceuticals

chris@byline.vc

Jenny Hogan

Centre for Quantum Technologies

jenny.hogan@nus.edu.sg
 

===

About Qubit Pharmaceuticals

Qubit Pharmaceuticals was founded in 2020 with the vision of co-developing, in partnership with pharmaceutical and biotech companies, safer and more effective new drugs. The company emerged from the academic research of five internationally renowned scientists: Louis Lagardère (Sorbonne University and CNRS), Matthieu Montes (CNAM), Jean-Philip Piquemal (Sorbonne University and CNRS), Jay Ponder (Washington University in St. Louis), and Pengyu Ren (University of Texas at Austin). Qubit Pharmaceuticals leverages its Atlas platform to discover new drugs through molecular simulation and modeling, accelerated by hybrid HPC and quantum computing.

The company’s multidisciplinary team, led by CEO Robert Marino, and its founders are based in France at the Paris Santé Cochin incubator, and in Boston, USA.

Qubit Pharmaceuticals was named a "2024 Technology Pioneer" by the World Economic Forum and has forged high-level partnerships, including with Institut Curie, Sorbonne University, and the Institute of Pharmacology at the University of Sherbrooke (Canada).

For further information, including the drug discovery portfolio, visit www.qubit-pharmaceuticals.com

About the Centre for Quantum Technologies, Singapore

 The Centre for Quantum Technologies (CQT) is Singapore’s flagship national research centre in quantum technologies. Supported under Singapore’s National Quantum Strategy, the centre has nodes at partner institutions and coordinates research talent across the country. CQT’s partner institutions are universities – the National University of Singapore, Nanyang Technological University, Singapore, and the Singapore University of Technology and Design – and the Agency for Science, Technology and Research.

CQT brings together physicists, computer scientists and engineers to do basic research on quantum physics and to build devices based on quantum phenomena. Experts in this new discipline of quantum technologies are applying their discoveries in computing, communications, and sensing.

For more information, please visit www.cqt.sg

About National University of Singapore (NUS)

The National University of Singapore (NUS) is Singapore’s flagship university, which offers a global approach to education, research and entrepreneurship, with a focus on Asian perspectives and expertise. We have 15 colleges, faculties and schools across three campuses in Singapore, with more than 40,000 students from 100 countries enriching our vibrant and diverse campus community. We have also established more than 20 NUS Overseas Colleges entrepreneurial hubs around the world.

Our multidisciplinary and real-world approach to education, research and entrepreneurship enables us to work closely with industry, governments and academia to address crucial and complex issues relevant to Asia and the world. Researchers in our faculties, research centres of excellence, corporate labs and more than 30 university-level research institutes focus on themes that include energy; environmental and urban sustainability; treatment and prevention of diseases; active ageing; advanced materials; risk management and resilience of financial systems; Asian studies; and Smart Nation capabilities such as artificial intelligence, data science, operations research and cybersecurity.

For more information on NUS, please visit nus.edu.sg.

About Quantinuum

Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity.* Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets. The company has a global workforce of approximately 700 employees, including top scientists and researchers. Over 70% of its technology team hold PhDs. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, and Singapore.

For more information, please visit www.quantinuum.com.

* As of December 31, 2025.

Longstanding quantum communication barrier broken




University of Copenhagen

Photonics wavelengths 

image: 

Description of the light wavelengths and the location of the new, coherent quantum dots in the telecom band

view more 

Credit: Marcus Albrechtsen, NBI





Quantum internet 

Researchers at the Niels Bohr Institute have broken a long standing barrier by managing to send single photons - that can’t be copied or split and thus are secure - in the network of optical fibers we already have. This opens up a broad range of applications relying on secure Quantum information.
 

Signal loss in optical fibers

Quantum dots are unsurpassed in their ability to generate coherent single photons - single particles of light, which cannot be split or copied and therefore are secure for quantum communication. So far, the problem was that the best quantum dots only worked around 930 nm wavelengths, which is far short of the telecommunication compatible wavelengths starting at 1260 nm. Only these longer wavelengths can be used to distribute the information-carrying photons far and has so far been restricted to sub-optimal platforms.

Now, scientists have managed to create a new type of quantum dot, which exploits the best of both worlds.

Noise is the enemy of everything quantum

Researchers working with quantum light sources have long attempted to work directly in the telecom band, but the photons produced at these wavelengths were always very noisy, as Leonardo Midolo explains. “Noisy in this context means that you couldn’t generate one photon after another with the same properties. The photons need to be perfectly identical, and achieving this level of quantum coherence in the telecom band has proven extremely challenging”.

Two major challenges overcome

Leonardo Midolo and his team have succeeded in overcoming two major challenges in one go: their photons are now coherent and identical, and they are emitted directly in the original telecom band (around 1300 nm),  the same wavelength used in today’s standard fiber-optic networks. This opens the door to linking photonic quantum technologies to the existing communication infrastructure.

For years, a kind of “accepted truth” circulated within the research community: yes, you can make photons in the telecom band, but they will be noisy and incoherent – which, as Leonardo notes, essentially meant “useless” for quantum applications. Their breakthrough challenges that assumption head-on.

This progress relies strongly on collaboration with the research group in Bochum, Germany, who optimized the growth of these ultra-low-noise quantum dot emitters.

At the Niels Bohr Institute, we then use advanced nanofabrication in our cleanroom to pattern these materials into quantum photonic circuits,” adds Marcus Albrechtsen, joint first author of the study. “We fabricate nanochips and probe them with lasers at low temperatures to confirm they emit highly coherent single photons.

Extras for free

Just as important – a kind of icing on the cake - is the fact that photonic integrated circuits, chip-scale optical circuits that miniaturize complex optical setups, are commonly made in silicon. It is the most common, cost-effective material for controlling and routing light on a chip. However, silicon absorbs much of the light in wavelengths below 1100 nanometers, which has so-far precluded the integration of near-infrared emitters like quantum dots in these photonic chips. This means that if you can make your photons coherent, identical, and operate at 1300 nm you can directly embed quantum-grade light sources with commercial silicon photonic chips. 
 

What happens now?

This achievement effectively removes one of the biggest roadblocks to build real, large‑scale quantum networks. It means quantum chips, quantum repeaters, and long‑distance quantum communication can now be built on top of the world’s existing fiber infrastructure. No complicated workarounds like nonlinear frequency conversion. Just plug‑and‑play quantum technology. In short: the door to a functional quantum internet is now officially open. And with this platform in hand, the race is on to build the first scalable quantum network.

Factbox: Quantum dots

A quantum dot is a collection of atoms, roughly 30,000 in these devices, that are different from their surroundings – so they behave like an artificial atom itself.

The individual dot is about 5,2 nm tall and 20 nm wide. They work as emitters for single photons in this way: The material boundaries of the Quantum dot locally form discrete energy levels like a real atom - discrete as in quantized and therefore "quantum" in nature.

This means that when a laser pulse/beam with many photons hits the quantum dot it gets excited, an electron is locally trapped in the dot and after a short time it decays and emits a single photon. Not two or a decimal amount but exactly one photon.

This single photon can be used for quantum computation or secure communication since information stored in a single photon cannot be copied.

 

Cal Poly research shows time-varying magnetic fields can engineer exotic quantum matter




California Polytechnic State University





Quantum technology has promising potential to revolutionize how large and complex amounts of information are processed. While already in use primarily in laboratory and research settings globally, quantum technologies are in a transition phase for broader industry applications across many economic sectors. 

In researching fundamental aspects of quantum physics, or the behavior of nature at the smallest scales — involving atoms, electrons and photons — a study led by Cal Poly Physics Department Lecturer Ian Powell analyzed how a changing magnetic field can make matter behave in unusual ways.  

Powell and student researcher Louis Buchalter, who graduated with a Cal Poly bachelor's degree in physics in 2025, published the article “Flux-Switching Floquet Engineering” in the journal Physical Review B, highlighting how changing magnetic fields over time in time can create quantum states that do not exist in any stationary material (remaining in the same state as time elapses). 

“On a big-picture level, I would describe this as an advance in our understanding of how time-dependent control can create and organize new forms of quantum matter,” Powell said. “The central idea is that useful quantum properties can depend not just on what a material is, but on how it is driven in time. In our case, we show that periodically changing a magnetic field can produce driven quantum phases with no static counterpart.” 

By engineering new quantum behaviors by timing the field, physicists can potentially create technologies that are very stable and hard to disrupt by “noise” or imperfections that can interfere with quantum technology functionality and avoid system errors. 

Admittedly, Powell said that it’s difficult to describe the technical aspects of the study to non-physicists. But conceptually, research points to possible routes for engineering these kinds of exotic driven quantum states in controlled platforms such as ultracold-atom experiments. 

“The most direct industry relevance of our study is to quantum computing and quantum simulation, rather than to a specific end-use sector at this stage,” Powell said. “Any eventual impact on areas like pharmaceuticals, finance, manufacturing or aerospace would likely be indirect, by contributing to the longer-term development of better quantum technologies. To move toward industry use, the next steps would be experimental validation and further work connecting these ideas to realistic quantum-device platforms.” 

Applying principles of physics, the work also revealed a mathematical organizing rule that echoes patterns more commonly associated with higher-dimensional quantum systems, suggesting that relatively simple driven systems may offer a new way to study that kind of physics.  

The research shows that the exotic driven phases can appear, but also uncovers a precise organizing rule for the topological phase diagram of the system, or a visual map that delineates distinct, stable quantum phases of matter based on unchanging topological numbers. 

The use of physics principles in quantum mechanics leverages the ability of a computational system to process information more quickly, run massive simulations, and comprehensively analyze far more data than classical computing.  

Magnetic fields are one of the main tools used to control and read out quantum bits (or qubits), the fundamental unit of information used in quantum technology.  Qubits are comparable to the units of 0s and 1s in classicalcomputing (applied in commonplace computing currently) used to represent physical electrical states.  

As a student researcher working alongside Powell, Buchalter said that co-authoring the article taught him “a lot about the process of conducting research and how new research findings are effectively communicated with the broader scientific community.” 

“I learned that research is rarely a straightforward process, often requiring persistence and creative problem solving during the course of a research project,” Buchalter said. “I believe our results help demonstrate the power of Floquet engineering for realizing quantum systems with highly-tunable properties, paving the way for further research into periodically driven quantum matter and the development of its applications.” 

Buchalter plans to pursue a Master of Science degree in materials science and engineering at the University of Washington in the fall, and to conduct experimental research on quantum matter. He’s considering pursuing a career at a national lab on the development of quantum devices after finishing his education. 

“I initially took on the project due to my interest in condensed matter physics, however, I became fascinated with the field of quantum materials through my experience,” Buchalter said. “I am very interested in continuing to study quantum matter and helping develop its applications in electronic and photonic devices.” 

 

New models reconstruct fault movement of the 2025 Kamchatka earthquake





Tohoku University

Thumbnail 

image: 

The July 29, 2025 Kamchatka earthquake. 

view more 

Credit: ©Tang et al.





On July 29, 2025, a magnitude 8.8 earthquake occurred near the Kamchatka Peninsula. It was so powerful, it ranks as the sixth-largest earthquake ever recorded by modern instruments. Using this giant earthquake as a learning opportunity, researchers at Tohoku University's International Research Institute of Disaster Science (IRIDeS) combined multiple datasets in order to reconstruct the movement of the faults (fractures in the earth's crust). Their analysis could help us better understand the tsunami risks faced by local communities, and how to protect them.

"The Kamchatka Peninsula is one of the most tectonically active plate boundaries in the world, known as a subduction zone," says Chi-Hsien Tang (IRIDeS). "This subduction zone produces some of the largest earthquakes on Earth, such as the magnitude 9.0 earthquake in 1952."

In subduction zones, when a tectonic plate dives beneath another, it can trigger a giant earthquake. However, how far earthquakes can extend along the plate interface and whether they reach the shallowest part of the subduction zone are not always clear. The 2025 Kamchatka earthquake was the first one in this region with detailed observations from modern satellites. By combining satellite radar imagery and GPS data, the researchers reconstructed how the fault moved during this giant earthquake.

The team built three slip models simulating the Kamchatka earthquake and compared them to actual tsunami records. Their results suggest that although the earthquake was large, the amount of movement near the seafloor was more limited than expected. Since seafloor movement is critical for tsunamis, it explains why the resulting tsunami in this case was smaller than early forecasts.

"It was so rewarding to see that our analysis consistently matched up with actual observational records," says Tang.

However, there is still a risk that the unruptured portions of the fault surrounding the slip zone may move in future earthquakes. The findings indicate that areas north of the rupture zone and the shallow portion of the fault may carry higher tsunami potential.

This work also suggests that land-based data alone is not enough to fully capture offshore earthquake behavior, highlighting the importance of seafloor observations. Accurate modeling and reconstruction of giant earthquakes such as these is expected to help with predicting the risk of dangerous tsunamis.

The findings were published in Geoscience Letters on April 17, 2026.


Figure 1 

Tectonic overview. Gray and red stars are the epicenters of the 1952 M9.0 and 2025 M8.8 earthquakes, while circles show their aftershocks. Dashed contours show the plate interface between the Pacific and the Okhotsk plates. 

Displacements measured by radar interferograms of (a-c) ALOS-2 and (d-f) Sentinel-1. White and light blue vectors are horizontal and vertical displacements from GPS stations. White stars show the earthquake epicenter. 

Tsunami simulations confirm no significant shallow slip during the earthquake. (a-c) Three models that can explain the observed displacements. (d) Location of the nearby DART tsunami stations. (e-f) Observed and simulated tsunami waveforms. Model C best explains the tsunami data. 

Credit

©Tang et al.



 

Scientists discover a new way to make drug-resistant cancer treatable again



Destabilizing DNA repair proteins restores tumor sensitivity to PARP inhibitor therapy




Institute for Basic Science

Figure 1. Schematic model of UNI418 mechanism 

image: 

UNI418 inhibits PIKfyve and PIP5K1C, leading to a reduction in intracellular IP6 levels. Under normal conditions, IP6 suppresses the activity of the Cul4A ubiquitin ligase complex, allowing key DNA repair proteins to remain stable. Upon UNI418 treatment, decreased IP6 relieves this suppression, resulting in activation of Cul4A. Activated Cul4A, in association with WDR5, promotes ubiquitination and degradation of homologous recombination proteins such as RAD51 and CHK1. Consequently, DNA repair is impaired, increasing the sensitivity of cancer cells to PARP inhibitors.

view more 

Credit: Institute for Basic Science





Cancer cells survive by repairing damage to their DNA—even damage that would normally be fatal. One of their most important defense systems is homologous recombination, a high-precision repair pathway that fixes broken DNA using key proteins such as RAD51 and CHK1. While therapies such as PARP inhibitors have successfully targeted this vulnerability, many tumors eventually regain their DNA repair ability and become resistant to treatment.

A research team led by Director MYUNG Kyungjae at the Center for Genomic Integrity within the Institute for Basic Science (IBS), in collaboration with LEE Joo-Yong (Chungnam University) has now uncovered a new strategy to overcome this resistance. Their findings show that cancer cells can be made vulnerable again—not by altering genetic mutations, but by destabilizing the DNA repair machinery itself.

In cells, DNA repair proteins are not static. Their levels are tightly regulated to maintain a balance between repair and genome stability. However, the researchers found that this balance can be deliberately disrupted.

Through a cell-based screening approach designed to identify modulators of replication stress responses, the team discovered a small molecule called UNI418. When applied to cancer cells, UNI418 caused a significant reduction in key DNA repair proteins, including RAD51 and CHK1. As these proteins were depleted, the cells lost their ability to efficiently repair DNA damage.

To understand how this happens, the researchers examined how these proteins are controlled. They found that UNI418 activates a protein degradation system known as the Cul4A ubiquitin ligase complex, which tags specific proteins for destruction. This effectively dismantles the DNA repair system from within.

Co-corresponding author Professor LEE Joo-Yong stated, “We identified a mechanism in which key DNA repair proteins are actively degraded inside the cell. This provides a new way to regulate homologous recombination beyond genetic mutations.”

The team further traced how this degradation pathway is triggered. UNI418 disrupts a signaling pathway involved in inositol phosphate metabolism, reducing the levels of a molecule called IP6. Under normal conditions, IP6 suppresses Cul4A activity. When IP6 levels drop, this suppression is lifted, allowing the degradation system to become active.

As a result, Cul4A—together with its adaptor protein WDR5—targets DNA repair proteins such as RAD51 for degradation, effectively shutting down homologous recombination.

Functionally, this creates a state similar to DNA repair deficiency, even in cancer cells that had previously restored their repair capacity. This finding is particularly important for overcoming resistance to PARP inhibitors, one of the major challenges in current cancer therapy.

The researchers tested whether this approach could improve treatment outcomes. In multiple cell-based experiments, UNI418 significantly increased the sensitivity of cancer cells to PARP inhibitors. Notably, it was also effective in PARP inhibitor-resistant cancer cells, restoring their responsiveness to treatment.

Co-corresponding author Director MYUNG Kyungjae added, “By weakening the DNA repair system, we can re-sensitize tumors that have become resistant to existing therapies. This suggests a new strategy for expanding the effectiveness of PARP inhibitors.”

The team further validated these findings in animal models. In tumor xenograft experiments, UNI418 suppressed tumor growth, particularly when combined with the PARP inhibitor Olaparib. Importantly, this effect was observed even in models that mimic treatment-resistant cancers.

These results indicate that cancer cells remain dependent on DNA repair systems even after developing resistance—and that disrupting protein stability can expose this vulnerability.

Beyond its therapeutic implications, the study also reveals a new biological connection between cellular metabolism and DNA repair. By linking IP6 signaling to the Cul4A-mediated protein degradation pathway, the work uncovers a previously unrecognized mechanism regulating genome stability.

Co-corresponding author Director MYUNG Kyungjae remarked, “This study demonstrates that controlling the stability of DNA repair proteins can directly impact cancer cell survival. It also highlights a new therapeutic direction for overcoming drug resistance.”

Ultimately, the findings suggest that drug-resistant cancers can be made vulnerable again—not by changing their genes, but by dismantling the systems they rely on to repair DNA. Although UNI418 itself will require further development, the mechanism identified in this study provides a promising foundation for next-generation combination therapies.

The study was published in Nature Communications on April 4, 2026.

First-ever "guideline for laser and aesthetic medicine" released in China: Establishes evidence-based standards for 26 common conditions



KeAi Communications Co., Ltd.






The Guideline for the Diagnosis and Treatment in Laser and Aesthetic Medicine has been o published in the Chinese Journal of Plastic and Reconstructive Surgery. "This is the first comprehensive guideline in China dedicated to standardizing the clinical practice of laser and aesthetic medicine," says Professor Xiaoxi Lin from Shanghai Ninth People's Hospital.

Jointly developed by the Chinese Society of Plastic Surgery of the Chinese Medical Association and the Chinese Society of Laser and Aesthetic Medicine of the Chinese Association of Plastics and Aesthetics, the guideline provides evidence-based recommendations for 26 diseases, ranging from pigmentary disorders to skin rejuvenation.

Filling the Gap in Standardization
The field of laser and aesthetic medicine has experienced rapid growth over the past three decades. However, the lack of systematic, high-evidence-level clinical guidelines has led to inconsistent treatment outcomes and safety concerns. To address this, a scientific committee was established, and 26 separate working groups were formed to review the latest international literature. The resulting guideline is registered on the International Practice Guidelines Registry and Transparency Platform (PREPARE-2023CN047).

Key Recommendations by Disease Type

  • Melasma: The guideline emphasizes that photoelectric technology is generally not recommended as a first-line treatment. For active-phase melasma, high-energy treatments should be avoided to prevent rebound. The low-fluence, large-spot Q-switched Nd:YAG laser is recommended as the preferred laser modality for stable-phase melasma.
  • Dermal spots (Nevus of Ota & Hori's Nevus): Nanosecond and picosecond lasers are confirmed as the mainstay of treatment. The 755 nm picosecond laser is highlighted for its efficacy in Hori's nevus, while Q-switched lasers remain highly effective for Nevus of Ota, especially in pediatric patients where earlier intervention is recommended.
  • Tattoo Removal: The picosecond laser is recommended as the first-line treatment due to its superior clearance rates and reduced number of sessions compared to traditional Q-switched lasers.
  • Scars (Hypertrophic Scars & Keloids): Monotherapy for keloids is discouraged due to high recurrence rates. The guideline advocates for multimodal therapy, such as combining fractional CO2 lasers with intralesional injections or radiotherapy, to minimize recurrence.
  • Aging and Vascular Lesions: For facial wrinkles and laxity, non-invasive fat reduction, and vascular malformations like Port-Wine Stains, the guideline details specific parameters for ablative/non-ablative lasers and pulsed dye lasers.

Expert Insight
By strictly grading the quality of evidence, the guideline aims to lead clinicians away from empirical treatment towards precise, evidence-based medicine. The goal is to maximize efficacy while minimizing adverse reactions like post-inflammatory hyperpigmentation.

Future Implications
This guideline serves as a reference for clinical physicians, nursing staff, and researchers. It is expected to improve the standard of care in hospitals across China and provide a valuable reference for global practitioners treating Asian skin types.

###

Contact the author:

Xiaoxi Lin, M.D., Ph.D.
Department of Laser and Aesthetic Medicine & Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine
Email: linxiaoxi@126.com

The publisher KeAi was established by Elsevier and China Science Publishing & Media Ltd to unfold quality research globally. In 2013, our focus shifted to open access publishing. We now proudly publish more than 200 world-class, open access, English language journals, spanning all scientific disciplines. Many of these are titles we publish in partnership with prestigious societies and academic institutions, such as the National Natural Science Foundation of China (NSFC).